Nuclear Magnetic Resonance Spectroscopy Market

The global nuclear magnetic resonance spectroscopy market is projected to reach USD 1.4 billion by 2027 from USD 1.1 Billion in 2022, at a CAGR of 5% during the forecast period. The growth in the nuclear magnetic resonance spectroscopy market is majorly driven by the expansion of the research pipeline of pharma and biotech companies, the increased number of drug development initiatives, and the higher adoption of integrated NMR platforms (such as NMR-LC and NMR-MS).

To know about the assumptions considered for the study, Request for Free Sample Report

However, technical problems associated with time-intensive analytical workflow and issues related to time-intensive analytical workflow premium product pricing and higher ownership costs are some factors expected to restrain market growth to a certain extent.

As of 2021, major players operating in nuclear magnetic resonance spectroscopy are Bruker Corporation (US), Thermo Fisher Scientific (US), Jeol Ltd (Japan), Oxford Instruments (UK), Nanalysis Corporation (Canada), Magritek (Germany), Niumag Corporation (China), Qone Tec AG (Switzerland), Cosa Xentaur (US) and Anasazi Instruments (US), among others.

Research Methodology

The study involved four major activities in estimating the current size of the nuclear magnetic resonance spectroscopy market. Exhaustive secondary research was conducted to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Top-down and bottom-up approaches were employed to estimate the total market size. After that, market breakdown and data triangulation procedures were used to estimate the size of segments and subsegments.

Secondary Research

The secondary sources referred to in this research study include corporate filings (such as annual reports, SEC filings, investor presentations, and financial statements); research journals; and press releases; trade, business, and professional associations. Secondary sources were used to identify and collect helpful information for this extensive and commercial study of the nuclear magnetic resonance spectroscopy market. Secondary research was mainly used to obtain critical information about the industry’s total pool of key players, market classification and segmentation according to industry trends to the bottom-most level, market trends, and necessary developments by both the public and private organizations in the nuclear magnetic resonance spectroscopy market.

The secondary sources referred to for this research study include government, independent or public, paid/private, and research databases, among others. Secondary data was collected and analysed to arrive at the overall market size of the cardiac marker testing market, which was further validated by primary research. Some of the critical secondary sources referred to during the preparation of this report are listed below-

• Governmental and inter-governmental sources & databases such as World Health Organization (WHO), World Bank, Organisation for Economic Co-operation, and Development (OECD), and Centers for Disease Control and Prevention (CDC), among others.
• Business and research articles such as Springer Nature, The Lancet, PubMed, and the US National Library of Medicine, among others.
• Company sources include annual reports, SEC filings, regulatory filings, investor presentations, press releases, and financial statements.

Primary Research

Extensive primary research was conducted after acquiring knowledge about the nuclear magnetic resonance spectroscopy market scenario through secondary research. A significant number of primary interviews were conducted from both the demand (Chemical & petrochemical industries, research and academic institutes, agriculture and food laboratories, and pharma-biotech companies) and supply sides (developers, manufacturers, and distributors of nuclear magnetic resonance spectroscopy products). The primaries interviewed for this study include experts from the molecular spectroscopy industry (such as CEOs, VPs, directors, sales heads, and marketing managers of tier 1, 2, and 3 companies engaged in offering nuclear magnetic resonance spectroscopy instruments across the globe) and administrators & purchase managers of pharma-biotech companies.

Around 65% and 35% of primary interviews were conducted from the supply and demand sides. A robust primary research methodology has been adopted to validate the report's contents and fill gaps. Telephonic and e-mail communications were adopted to conduct interviews (questionnaires were designed and sent to primary participants at their convenience).

The nuclear magnetic resonance spectroscopy market comprises several stakeholders, including diagnostic laboratories, clinical testing facilities, research laboratories, academic institutions, and molecular spectroscopy laboratories. The demand side of this market has been characterized by the expansion of the research pipeline of pharma and biotech companies, the increased number of drug development initiatives, and the higher adoption of integrated NMR platforms (such as NMR-LC and NMR-MS). Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the nuclear magnetic resonance spectroscopy market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

• The key players in the industry and markets have been identified through extensive secondary research
• The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research
• All percentage shares split, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size—using the market size estimation processes as explained above—the nuclear magnetic resonance spectroscopy market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the nuclear magnetic resonance spectroscopy industry.

Report Objectives

• To define, describe, and forecast the nuclear magnetic resonance spectroscopy market by technology, product, type, application, end-user, and region
• To provide detailed information about significant factors influencing the market growth (key drivers, restraints, opportunities, and industry-specific challenges)
• To strategically analyze micromarkets1 concerning individual growth trends, prospects, and their contributions to the overall nuclear magnetic resonance spectroscopy market
• To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
• To forecast the market value of various segments and sub-segments concerning five main regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
• To profile the key players active in the nuclear magnetic resonance spectroscopy market and comprehensively analyze their global revenue shares and core competencies2
• To track and analyze competitive market-specific developments such as product approvals & commercialization, agreements, partnerships, collaborations, acquisitions, and expansions in the nuclear magnetic resonance spectroscopy market

To know about the assumptions considered for the study, download the pdf brochure

Want to explore hidden markets that can drive new revenue in Nuclear Magnetic Resonance Spectroscopy Market?

Unlock Insights

Scope of the Report

This research report categorizes the nuclear magnetic resonance spectroscopy market based on technology, product, type, application, end-user, and region

By Technology

• Fourier-Transform NMR Spectroscopy
• Continuous-Wave NMR Spectroscopy
• Multi-dimensional NMR spectroscopy
• Solid-State NMR Spectroscopy

By Product

• Instruments  
• Reagents and Consumables
• Software and Services

By Type

• Low-field NMR Spectroscopy
• High-field NMR Spectroscopy

By Application

• Pharmaceutical Applications
• Food & Beverage Testing
• Biotechnology & Biopharmaceutical Applications
• Environmental Testing
• Academic Research
• Other Applications

By End User

• Chemical & Petrochemical industries
• Academia and government organizations
• Pharma-biotech companies
• Agriculture and food
• Other end users

By Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • RoE
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • RoAPAC
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• The Middle East and Africa

Available Customizations

With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for the nuclear magnetic resonance spectroscopy market report:

PRODUCT ANALYSIS

• Product Matrix, which gives a detailed comparison of the product portfolios of the top five global players

PRODUCT ANALYSIS

• Further breakdown of the Rest of Europe nuclear magnetic resonance spectroscopy market into Russia, Portugal, Belgium, Denmark, Switzerland, and other European countries (aggregated)

COMPANY INFORMATION

• Detailed analysis and profiling of additional market players (up to 5 OEM

To speak to our analyst for a discussion on the above findings, click Speak to Analyst